Latest Updates

The new website will be interactive have a responsive layout

The drug, Aliqopa, known also as copanlisib, is a kinase inhibitor that blocks certain enzymes that promote cell growth

Pfizer and Astellas jointly sell Xtandi in the US, while Astellas owns the rights to develop and sell Xtandi outside the US

The proposal, mooted by the regulator, comes amid concerns over anti-competitive practices in the pharmaceutical and healthcare…

The reason for the recall is current CGMP deviations

The first module for the first batch will start on Sept 26

The product is a generic version of GD Searle's Flagyl tablets

Special Secretary AYUSH gives away prizes to winners of the contest

The findings include updated survival data showing a 19 per cent reduction in the risk of death over standard treatment in the…

Selected populations of patients to be treated at major cancer centres with the potential checkpoint inhibitor as a once daily…